12.06
-0.36 (-2.9%)
-0.36 (-2.9%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 28,675 |
|
|||||
| News | - | ||||||
| Day High | 12.49 | Low High |
|||||
| Day Low | 11.9814 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Annovis Bio Inc | ANVS | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.36 | -2.9% | 12.06 | 18:54:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.30 | 11.9814 | 12.49 | 12.06 | 12.42 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 483 | 28,675 | $ 12.17 | $ 349,014 | - | 8.385 - 40.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 162 | $ 12.06 | USD |
Period:
Draw Mode:
Annovis Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 98.46M | 8.16M | 5.64M | $ - | $ - | -1.90 | -4.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 32.10% |
Annovis Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANVS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.84 | 12.89 | 11.2101 | 12.24 | 23,780 | 0.22 | 1.86% |
| 1 Month | 13.02 | 13.5599 | 9.84 | 11.92 | 32,072 | -0.96 | -7.37% |
| 3 Months | 8.75 | 15.80 | 8.50 | 13.32 | 80,150 | 3.31 | 37.83% |
| 6 Months | 14.78 | 15.80 | 8.385 | 12.97 | 58,995 | -2.72 | -18.4% |
| 1 Year | 39.54 | 40.64 | 8.385 | 25.16 | 126,284 | -27.48 | -69.5% |
| 3 Years | 8.9875 | 132.00 | 2.418 | 38.39 | 353,490 | 3.07 | 34.19% |
| 5 Years | 8.9875 | 132.00 | 2.418 | 38.39 | 353,490 | 3.07 | 34.19% |
Annovis Bio Description
| Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. |